Carminomycin versus doxorubicin in advanced breast cancer, a randomized phase II study of the E.O.R.T.C. breast cancer cooperative group-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Carminomycin versus doxorubicin in advanced breast cancer, a randomized phase II study of the E.O.R.T.C. breast cancer cooperative group

Published:1986-05 Issue:5 Volume:22 Page:601-605
ISSN:0277-5379
Container-title:European Journal of Cancer and Clinical Oncology
language:en
Short-container-title:European Journal of Cancer and Clinical Oncology

Author:

van Oosterom A.T.,Mouridsen H.T.,Wildiers J.,Paridaens R.,Cocconi G.,Rotmensz N.,Sylvester R.

Publisher

Elsevier BV

Subject

Oncology

Reference17 articles.

1. The chemical therapy of breast cancer;Carter;Semin Oncol,1974

2. Risk factors for doxorubicin-induced congestive heart failure;Von Hoff;Ann Intern Med,1979

3. A new antitumor antibiotic, carminomycin (NSC-180024);Gause;Cancer Chemother Rep,1974

4. Experimental evaluation of anthracycline analogs;Casazza;Cancer Treat Rep,1979

5. Molecular pharmacological differences between carminomycin and its analog, carminomycin-11-methyl-ether, and Adriamycin;DuVernay;Cancer Res,1980

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanoparticle Characterization: State of the Art, Challenges, and Emerging Technologies;Molecular Pharmaceutics;2013-03-21

2. Carminomycin;xPharm: The Comprehensive Pharmacology Reference;2007

3. The role of the liposomal anthracyclines and other systemic therapies in the management of advanced breast cancer;Seminars in Oncology;2004-12

4. Caelyx (stealth liposomal doxorubicin) in the treatment of advanced breast cancer;Critical Reviews in Oncology/Hematology;2001-02

5. Treatment of advanced breast cancer with sterically stabilized liposomal doxorubicin: results of a multicenter phase II trial.;Journal of Clinical Oncology;1997-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3